Exo Iris

by Exo Imaging, Inc.  · Based in United States → — Handheld ultrasound with integrated AI for cardiac and lung assessment.
Cardiology Critical Care Emergency Medicine

Enterprise
Regulatory Status Disclosed

Overview

Exo Iris is a groundbreaking handheld ultrasound device designed to empower physicians with advanced imaging capabilities at the point of care. Its portability and ease of use make it an invaluable asset in various clinical settings, from emergency departments to primary care offices.

The device features AI-powered guidance that assists users in acquiring optimal ultrasound images, reducing the learning curve and improving diagnostic confidence. For cardiac assessment, Exo Iris offers automated ejection fraction (EF) calculations and other key cardiac metrics, aiding in the rapid evaluation of heart function. In lung assessment, its AI can help identify and quantify B-lines, a critical indicator for conditions such as pulmonary edema and interstitial lung disease.

Exo Iris is designed to streamline workflows, allowing physicians to make faster, more informed decisions. The integration of AI not only enhances diagnostic accuracy but also contributes to more efficient patient management. By providing immediate access to high-quality ultrasound imaging and AI-driven analysis, Exo Iris aims to transform how physicians approach patient care, enabling earlier detection and intervention.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Handheld ultrasound device
  • Integrated FDA-cleared AI
  • Real-time scanning assistance
  • Automated cardiac assessment (e.g., EF calculation)
  • Automated lung assessment (e.g., B-line quantification)
  • High-resolution imaging
  • Portable and easy to use
  • Streamlined workflow
  • Point-of-care diagnostics

Use Cases

  • Cardiac function assessment
  • Lung pathology detection (e.g., pulmonary edema)
  • Emergency department diagnostics
  • Critical care monitoring
  • Primary care screening
  • Procedural guidance

Details

Category Cardiology AI, Clinical Decision Support & Reference, Radiology & Imaging AI
Pricing Enterprise
API Available No
Data Export Yes
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Critical Care, Emergency Medicine, Internal Medicine, Pulmonology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Exo Iris

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Exo Iris.

Loading videos...

View all on YouTube

No FAQs available yet for this tool.

Related Tools

PanEcho
Yale School of Medicine (Cardiovascular Data Science Lab)
Cardiology AI
PanEcho is an AI tool from Yale School of Medicine that interprets echocardiograms with high accuracy, performing 39 diagnostic tasks and detecting conditions like severe aortic stenosis and systolic dysfunction.
Hexoskin Medical
Hexoskin
Cardiology AI
EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.

See all Cardiology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-09 | First Added: 2026-11-09

Investors who backed Exo Iris

Funded through the company that built this tool.

AI Tool Finder
AI-powered search. Results may not be comprehensive.